Results
1 -
10 of
71Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics, Current Antipsychotics Schizophrenia, 5-HT2A Receptors in the Central Nervous System II. In vitro evidence that (???)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors, Journal of Neural Transmission Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone, Journal of Neural Transmission I. In vivo evidence for partial agonist effects of (???)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors, Journal of Neural Transmission In Vivo DA D1 Receptor Selectivity of NNC 112 and SCH 23390, Molecular Imaging and Biology 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion, Psychopharmacology Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants, Psychopharmacology Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs, European Archives of Psychiatry and Clinical Neuroscience